Stage <scp>III</scp> substaging and outcomes in patients with bladder cancer undergoing radical cystectomy

This prognostic study supports the current stage III substaging of patients with bladder cancer who underwent RC. Importantly, there was no difference in OS between pT3-4N0 and pTanyN1 in patients with stage IIIA bladder cancer. These findings may help guide treatment decisions for patients with stage III operable bladder cancer.

Authors

Institutions

Publication Details

Journal
International Journal of Urology
Published
2025-02-05
DOI
https://doi.org/10.1111/iju.70005
Citations
4
Primary Topic
Bladder and Urothelial Cancer Treatments
Type
article
Field-Weighted Citation Impact
8.03
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Stage III substaging and outcomes in patients with bladder cancer undergoing radical cystectomy

Naotaka Nishiyama, Taketo Kawai, Sho Sekito, Tomokazu Sazuka et al.
4 citations
International Journal of Urology
Bladder and Urothelial Cancer Treatments
8.03
article

Stage III substaging and outcomes in patients with bladder cancer undergoing radical cystectomy

Naotaka Nishiyama, Taketo Kawai, Sho Sekito, Tomokazu Sazuka, Fumihiko Urabe, Keiji Yasue, Wataru Fukuokaya, Yoshiyuki Matsui, Shuichi Tatarano, Jun Miki, Katsuyoshi Hashine, Takeshi Sano, Kenichiro Shiga, Yusuke Sugino, Rikiya Taoka, Takuji Hayashi, Koichiro Wada, Junichi Inokuchi, Hiroaki Matsumoto, Soki Kashima, Makito Miyake, Kiyoaki Nishihara, Yuto Matsushita, Yoji Murakami, Ryoichi Saito, Shuhei Hara, Hirohito Naito, Noriya Yamaguchi, Hiroyuki Nishiyama, Shotaro Nakanishi, Kei Daizumoto, Takashige Abe, Takahiro Kimura, Ayumu Matsuda, Shingo Yamamoto, Minoru Kato, Takashi Kawahara, Hiroshi Kitamura, Shingo Hatakeyama, Masato Fujii, Ryo Maruyama
article en
4 citations

Abstract

This prognostic study supports the current stage III substaging of patients with bladder cancer who underwent RC. Importantly, there was no difference in OS between pT3-4N0 and pTanyN1 in patients with stage IIIA bladder cancer. These findings may help guide treatment decisions for patients with stage III operable bladder cancer.

International Journal of UrologyVol. 32(5)
Kurume University (JP), Kagoshima University (JP), Jikei University School of Medicine (JP), University of Miyazaki (JP), Kansai Medical University (JP), Kyushu University (JP), Hyogo Medical University (JP), University of Tsukuba (JP), Hirosaki University (JP), Chiba University (JP), ROHM (JP), Shimane University (JP), Yamaguchi University (JP), Mie University (JP), Kagawa University (JP), Akita University (JP), Hokkaido University (JP), Kyoto University (JP), Hamamatsu University School of Medicine (JP), University of the Ryukyus (JP), Kurashiki Central Hospital (JP), The Jikei University Hospital (JP), Aichi Cancer Center (JP), Jikei University Kashiwa hospital (JP), Shikoku Cancer Center (JP), Harasanshin Hospital (JP), Osaka International Cancer Institute (JP), Tokyo National Hospital (JP), University of Toyama (JP), Osaka Metropolitan University (JP), Tottori University (JP), Nara Medical University (JP), Tokyo Metropolitan University (JP), Niigata University (JP), The University of Tokyo (JP), International University of Health and Welfare (JP), Tokushima University (JP), Kumamoto University (JP)
Good health and well-being
Openalex Percentile: Top 3%
Bladder and Urothelial Cancer Treatments
8.03
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.